Rheumatoid arthritis (RA) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051134
This document outlines details of PBS-subsidised biological medicines for patients with rheumatoid arthritis (RA).
RA and listing dates
RA is a form of arthritis that causes pain, swelling and loss of joint function.
Listing dates:
- etanercept - 1 August 2003
- infliximab - 1 February 2004
- adalimumab - 1 May 2004
- abatacept - 1 March 2008
- certolizumab - 1 August 2010
- golimumab - 1 August 2010
- tocilizumab - 1 August 2010
- tofacitinib - 1 October 2015
- baricitinib - 1 September 2018
- upadacitinib - 1 May 2020
See Written Authority Required Drugs for more details.
Treatment specifics
Transition from JIA/sJIA to RA
A patient may receive:
- treatment through initial 2 restriction using grandfather baseline scores (change or recommencement of treatment after a break in biological medicine of less than 24 months) when:
- they have received PBS-subsided treatment for paediatric severe active juvenile idiopathic arthritis (JIA) or systemic juvenile idiopathic arthritis (sJIA), and
- the condition has been reclassified to rheumatoid arthritis as an adult
Treatment failures
- A patient cannot trial and fail (or cease to respond) to the same PBS-subsidised biological medicine
- Once a patient has either failed or ceased to respond to a PBS-subsidised biologic medicine for this condition 5 times in a lifetime, they will no longer be eligible to receive further PBS-subsidised treatment for this condition
Enquiries
Transfer enquiries about prescription arrangements to PBS Complex Drugs Program, and choose the option relevant to the condition treated.
The Resources page contains:
- application forms
- calculation sheets
- contact details
- restriction and item codes
- FAQs from Service Officers
- the PBS schedule
- Services Australia website link
Related links
Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)
Process telephone Authority approval application
Processing and National Demand Allocation (PaNDA)
Processing Complex Authority Required Listings
Processing Written Authority requests
Written Authority Required Drugs